Addition of metabolomics to the omics spectrum for cancer biomarker development– demonstration with the KrasG12D mouse model for pancreatic carcinoma

BMC Genomics

Oral Presentation

Evagelia C. Laiakis¹  Albert J. Fornace²  Amrita Cheema³  Anton Wellstein³  Joseph J. LaConti³ 

[1] Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, 20057, Washington, DC, USA;Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, 20057, Washington, DC, USA;Department of Oncology, Georgetown University Medical Center, 20057, Washington, DC, USA;Department of Oncology, Georgetown University Medical Center, 20057, Washington, DC, USA;

关键词: Pancreatic Cancer;    Ultra Performance Liquid Chromatography;    Patient PDAC;    Late Stage Diagnosis;    PDAC Tissue;   

DOI  :  10.1186/1471-2164-15-S2-O4

来源: Springer

【 授权许可】

Unknown   
© Laiakis et al; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.